Obligacje
Poniżej znajduje się lista obligacji korporacyjnych Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| 5,69% | 0 | 55,19% | 1,625% | 2043-09-14 | 250 M GBP | 1 000,00 GBP | 100 000,00 GBP | Eli Lilly & Co. | |
| 5,65% | 44 K | 88,40% | 4,650% | 2044-06-15 | 38,34 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,53% | 0 | 78,99% | 4,150% | 2059-03-15 | 591,29 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,49% | 11,14 M | 101,70% | 5,600% | 2065-02-12 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,46% | 1,22 M | 95,84% | 5,200% | 2064-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,43% | 0 | 57,23% | 2,250% | 2050-05-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,42% | 698 K | 94,79% | 5,100% | 2064-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,42% | 16,77 M | 103,64% | 5,650% | 2065-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,40% | 3,87 M | 92,69% | 4,950% | 2063-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,35% | 0 | 55,17% | 2,500% | 2060-09-15 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,33% | 43,92 M | 103,13% | 5,550% | 2055-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,33% | 7,41 M | 93,46% | 4,875% | 2053-02-27 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,33% | 615 K | 95,90% | 5,050% | 2054-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,32% | 0 | 81,75% | 3,950% | 2049-03-15 | 958,15 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,31% | 11,07 M | 95,46% | 5,000% | 2054-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,30% | 38,81 M | 102,82% | 5,500% | 2055-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,29% | 30 K | 80,91% | 3,700% | 2045-03-01 | 386,8 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,27% | 800 K | 83,15% | 3,950% | 2047-05-15 | 346,95 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,23% | 0 | 87,14% | 3,875% | 2039-03-15 | 240,25 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,01% | 4 K | 113,94% | 6,770% | 2036-01-01 | 158,56 M USD | 1 000,00 USD | 1 000,00 USD | Eli Lilly & Co. | |
| 4,94% | 50 K | 100,00% | 5,000% | 2026-02-27 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,69% | 15 K | 111,44% | 5,950% | 2037-11-15 | 266,83 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,53% | 8,79 M | 102,84% | 4,900% | 2035-10-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,51% | 1,04 M | 109,14% | 5,550% | 2037-03-15 | 444,73 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,47% | 4,64 M | 104,68% | 5,100% | 2035-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,43% | 3,4 M | 101,24% | 4,600% | 2034-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,40% | 0 | 45,92% | 1,375% | 2061-09-14 | 700 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 4,39% | 880 K | 102,10% | 4,700% | 2034-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,23% | 300 K | 102,89% | 4,700% | 2033-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,20% | 2,34 M | 102,04% | 4,550% | 2032-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,11% | 926 K | 104,28% | 4,900% | 2032-02-12 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,08% | 0 | 53,38% | 1,125% | 2051-09-14 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 4,06% | 0 | 64,27% | 1,700% | 2049-11-01 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 4,03% | 5 M | 101,04% | 4,250% | 2031-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,94% | 0 | 98,27% | 3,375% | 2029-03-15 | 930,56 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,91% | 470 K | 103,22% | 4,750% | 2030-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,80% | 482 K | 102,10% | 4,500% | 2029-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,79% | 2,11 M | 101,42% | 4,200% | 2029-08-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,78% | 11,86 M | 100,83% | 4,500% | 2027-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,72% | 582 K | 100,74% | 4,000% | 2028-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,70% | 25 K | 99,18% | 3,100% | 2027-05-15 | 401,45 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,69% | 2,07 M | 100,77% | 4,150% | 2027-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,66% | 10 K | 102,32% | 5,500% | 2027-03-15 | 364,32 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,64% | 170 K | 101,92% | 4,550% | 2028-02-12 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,08% | 0 | 82,32% | 0,500% | 2033-09-14 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,91% | 0 | 87,69% | 0,625% | 2031-11-01 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,78% | 0 | 97,23% | 2,125% | 2030-06-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,23% | 0 | 99,69% | 1,625% | 2026-06-02 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 0,51% | 0 | 99,85% | 0,450% | 2028-05-24 | 400 M CHF | 5 000,00 CHF | 5 000,00 CHF | Eli Lilly & Co. | |
| — | 14,21 M | 100,82% | 4,758% | 2028-10-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |